Balaji Amines Reports Q1FY26 Results: Revenue Up 2% QoQ, Margins Under Pressure
Balaji Amines reported consolidated revenue of ₹367.00 crore for Q1FY26, a 2% increase from Q4FY25 but a 7% year-on-year decline. Total volumes increased to 27,570 MT. Despite revenue growth, profitability metrics showed pressure with EBITDA at ₹64.00 crore and PAT at ₹37.00 crore, both declining year-on-year. The company continues to progress on expansion projects including a DME plant, NMM facility, and upgraded Acetonitrile plant. Balaji Amines commissioned an 8 MW DC solar power plant in April 2025 for sustainability and cost reduction. The company maintains a zero-debt status on a standalone basis.

*this image is generated using AI for illustrative purposes only.
Balaji Amines , a leading manufacturer of aliphatic amines and specialty chemicals, has released its financial results for the first quarter of fiscal year 2026 (Q1FY26), showing mixed performance with revenue growth but margin pressure.
Revenue and Volume Growth
The company reported consolidated revenue of ₹367.00 crore for Q1FY26, marking a 2% increase from ₹361.00 crore in Q4FY25. However, this figure represents a 7% year-on-year decline from ₹393.00 crore in Q1FY25. Total volumes increased to 27,570 MT in Q1FY26 from 25,871 MT in the previous quarter, indicating improved demand.
Product-wise Performance
The volume breakdown for Q1FY26 was as follows:
- Amines: 7,573 MT
- Amines Derivatives: 8,108 MT
- Specialty Chemicals: 11,889 MT
Profitability Under Pressure
Despite the revenue growth, the company's profitability metrics showed signs of pressure:
Metric | Q1FY26 | Q4FY25 | Q1FY25 | QoQ Change | YoY Change |
---|---|---|---|---|---|
EBITDA (₹ crore) | 64.00 | 68.00 | 74.00 | -5.90% | -13.50% |
EBITDA Margin | 17.00% | 19.00% | 19.00% | -2 pp | -2 pp |
PAT (₹ crore) | 37.00 | 40.00 | 46.00 | -7.50% | -19.60% |
PAT Margin | 10.00% | 11.00% | 12.00% | -1 pp | -2 pp |
The company's diluted Earnings Per Share (EPS) for Q1FY26 stood at ₹11.73, compared to ₹12.36 in Q4FY25.
Expansion Projects and Future Outlook
Balaji Amines continues to progress on multiple expansion projects:
- Dimethyl Ether (DME) Plant: Expected to be commissioned in FY2025-26.
- N-Methyl Morpholine (NMM) Facility: 5,000 TPA capacity, scheduled for commissioning in FY2025-26.
- Upgraded Acetonitrile Plant: Planned for commissioning in FY2026-27.
The company's subsidiary, Balaji Speciality Chemicals, has received Mega Project status from the Maharashtra government for its ₹750.00 crore expansion. This project includes products like Hydrogen Cyanide and EDTA, with commissioning planned for FY2026-27.
Sustainable Initiatives
In line with its commitment to sustainability and cost reduction, Balaji Amines commissioned an 8 MW DC (6 MW AC) solar power plant in April 2025. This initiative is expected to substantially reduce power costs across all plants and lower the company's carbon footprint.
Financial Position
The company maintains a zero-debt status on a standalone basis, showcasing its strong financial discipline.
Balaji Amines' management remains focused on its expansion strategy, aiming to strengthen its market position in high-value derivatives and specialty chemicals. The company's ongoing projects and sustainable initiatives are expected to drive long-term growth and operational efficiency.
Historical Stock Returns for Balaji Amines
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
+2.05% | +1.17% | -1.43% | +29.21% | -33.58% | +76.89% |